HomeMRKR • NASDAQ
Marker Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.25M | 113.13% |
Operating expense | 1.03M | -25.42% |
Net income | -3.84M | -36.91% |
Net profit margin | -170.43 | 35.76% |
Earnings per share | -0.42 | — |
EBITDA | — | — |
Effective tax rate | -1.32% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.19M | 27.01% |
Total assets | 22.02M | 28.58% |
Total liabilities | 3.46M | 12.67% |
Total equity | 18.56M | — |
Shares outstanding | 10.71M | — |
Price to book | 0.73 | — |
Return on assets | -58.62% | — |
Return on capital | -74.24% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.84M | -36.91% |
Cash from operations | -4.70M | -98.65% |
Cash from investing | — | — |
Cash from financing | 14.90M | 289,985.90% |
Net change in cash | 10.19M | 531.45% |
Free cash flow | -3.28M | -134.07% |
Previous close
$1.26
Day range
$1.23 - $1.28
Year range
$0.96 - $5.99
Market cap
13.92M USD
Avg Volume
54.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1992
Headquarters
Website
Employees
5
